当前位置:首页 - 行情中心 - 可孚医疗(301087) - 财务分析

可孚医疗

(301087)

  

流通市值:100.20亿  总市值:121.84亿
流通股本:1.94亿   总股本:2.36亿

可孚医疗(301087)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润1.07亿元,每股收益0.52元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益476790.27万元,未分配利润63076.51万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产691338.70万元,负债214548.43万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入1,012,368,240.573,387,499,253.242,397,791,920.731,495,764,000.12
营业总成本885,037,584.773,038,805,623.012,140,937,840.581,324,393,499.85
其他经营收益
营业利润128,666,168.48429,044,340.65301,810,929.65197,076,115.25
利润总额129,032,197.45425,842,807.11304,177,103.13199,658,996.39
净利润107,411,758.99370,316,214.99259,507,645.73166,642,911.6
每股收益
其他综合收益-2,847,497.23-1,767,715.86643,588.1-
综合收益总额104,564,261.76368,548,499.13260,151,233.83166,642,911.6
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计4,163,988,017.843,835,321,664.483,894,095,362.253,764,999,620.85
非流动资产:
非流动资产合计2,749,398,987.442,793,593,565.552,646,196,983.252,583,062,050.13
资产总计6,913,387,005.286,628,915,230.036,540,292,345.56,348,061,670.98
流动负债:
流动负债合计2,010,042,327.321,588,765,842.511,637,988,672.11,419,124,954.68
非流动负债:
非流动负债合计135,441,955.2137,260,900.1151,810,702.44154,512,523.24
负债合计2,145,484,282.521,726,026,742.611,789,799,374.541,573,637,477.92
所有者权益(或股东权益):
归属于母公司股东权益合计4,731,839,687.124,866,857,736.114,713,657,384.444,737,676,805.62
股东权益合计4,767,902,722.764,902,888,487.424,750,492,970.964,774,424,193.06
负债和股东权益合计6,913,387,005.286,628,915,230.036,540,292,345.56,348,061,670.98
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,117,854,092.743,779,567,063.092,636,305,027.871,633,833,084.46
经营活动现金流出小计1,015,293,959.853,083,841,246.382,046,313,639.681,282,399,646.74
经营活动产生的现金流量净额102,560,132.89695,725,816.71589,991,388.19351,433,437.72
投资活动产生的现金流量:
投资活动现金流入小计151,986,902.432,288,300,077.521,311,720,780.841,191,807,578.55
投资活动现金流出小计342,889,074.82,357,260,147.761,477,933,054.821,145,094,643.56
投资活动产生的现金流量净额-190,902,172.37-68,960,070.24-166,212,273.9846,712,934.99
筹资活动产生的现金流量:
筹资活动现金流入小计667,044,378.361,246,432,050.11,136,639,341.57597,133,829.84
筹资活动现金流出小计477,075,593.11,715,178,834.641,486,487,292.43992,524,915.49
筹资活动产生的现金流量净额189,968,785.26-468,746,784.54-349,847,950.86-395,391,085.65
汇率变动对现金及现金等价物的影响-3,225,998.04-3,429,799.77-2,049,743.68-543,325.85
现金及现金等价物净增加额98,400,747.74154,589,162.1671,881,419.672,211,961.21
期末现金及现金等价物余额1,392,976,048.441,294,575,300.71,211,867,558.211,142,198,099.75
补充资料:
现金及现金等价物的净增加额-154,589,162.16-2,211,961.21
最新报告期:2026-05-06
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
太平洋谭紫媚2.242.883.602026-05-06
信达证券唐爱金2.222.893.652026-05-05
财信证券龙靖宁2.242.783.302026-05-05
中泰证券祝嘉琦,谢木青2.212.803.432026-05-02
中信建投华冉,王在存,贺菊颖2.182.623.212026-04-29
TOP↑